Cargando…

Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy

Glioblastoma (GBM) is a central nervous system tumor with poor prognosis due to the rapid development of resistance to mono chemotherapy and poor brain targeted delivery. Chemoimmunotherapy (CIT) combines chemotherapy drugs with activators of innate immunity that hold great promise for GBM synergist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanjie, Wang, Wendie, Zhang, Dongya, Sun, Yajing, Li, Fangzhou, Zheng, Meng, Lovejoy, David B., Zou, Yan, Shi, Bingyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190947/ https://www.ncbi.nlm.nih.gov/pubmed/37325609 http://dx.doi.org/10.1002/EXP.20210274

Ejemplares similares

Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
por: Zou, Yan, et al.
Publicado: (2023)

Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma
por: Zhang, Dongya, et al.
Publicado: (2022)

BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014)

A chemical toolbox for the study of bromodomains and epigenetic signaling
por: Wu, Qin, et al.
Publicado: (2019)

Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
por: Morgado-Pascual, Jose Luis, et al.
Publicado: (2019)

Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
por: Meng, Wei, et al.
Publicado: (2018)

A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line
por: Mqoco, Thandi, et al.
Publicado: (2019)

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
por: Tang, Yujie, et al.
Publicado: (2014)

Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)
por: Basuroy, Tupa, et al.
Publicado: (2022)

Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
por: Segatto, Marco, et al.
Publicado: (2017)

Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention
por: Groves, Ian J., et al.
Publicado: (2021)

Orchestrating epigenetic readers: Progress in understanding the functions of bromodomain-containing protein 4 complexes
por: Brasier, Allan R.
Publicado: (2023)

Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation
por: Martella, Noemi, et al.
Publicado: (2023)

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
por: Filippakopoulos, Panagis, et al.
Publicado: (2012)

337 Targeting metabolic and epigenetic programs to re-sensitize glioblastoma to chemotherapy
por: Rowland, Emma, et al.
Publicado: (2023)

The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells
por: Pan, Hanyu, et al.
Publicado: (2017)

Bromodomains as therapeutic targets
por: Muller, Susanne, et al.
Publicado: (2011)

Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma
por: Liu, Xiaohua, et al.
Publicado: (2021)

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation
por: Meier, Julia C., et al.
Publicado: (2017)

Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions
por: Belter, Agnieszka, et al.
Publicado: (2020)

The effects of histone crotonylation and bromodomain protein 4 on prostate cancer cell lines
por: Xu, Xiaolin, et al.
Publicado: (2021)

Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy
por: BAK, DONG-HO, et al.
Publicado: (2016)

Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
por: Cipriano, Alessandra, et al.
Publicado: (2022)

Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent Differentiation
por: Colardo, Mayra, et al.
Publicado: (2023)

Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy
por: Gargano, Deborah, et al.
Publicado: (2023)

Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma
por: Yang, Chuanhe, et al.
Publicado: (2023)

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma
por: Yu, Bo, et al.
Publicado: (2022)

Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations
por: Shi, Mingsong, et al.
Publicado: (2023)

Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs
por: Muddassir, Mohd., et al.
Publicado: (2020)

Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis
por: Yang, Minghua, et al.
Publicado: (2022)

A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy
por: Hu, Doudou, et al.
Publicado: (2022)

Is Glioblastoma an Epigenetic Malignancy?
por: Maleszewska, Marta, et al.
Publicado: (2013)

Epigenetic Targeting of Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018)

Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010)

Bromodomain Proteins in HIV Infection
por: Boehm, Daniela, et al.
Publicado: (2013)

Unveiling the folding mechanism of the Bromodomains
por: Petrosino, Maria, et al.
Publicado: (2017)

Spotlight on Plant Bromodomain Proteins
por: Bardani, Eirini, et al.
Publicado: (2023)

Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets
por: Lavogina, Darja, et al.
Publicado: (2021)

Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma
por: Yang, Chuanhe, et al.
Publicado: (2021)

Nanorods with multidimensional optical information beyond the diffraction limit
por: Wen, Shihui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41g8protf7f5949otmmrm3u3ss